LIWANLI Innovation Co., Ltd. (3054.TW) TAI

Currency In TWD

AD

LIWANLI Innovation Co., Ltd.

Address

No. 258, Liancheng Road

New Taipei City, 235

Taiwan (Province of China)

Phone

886 2 8221 3985

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

360

First IPO Date

November 19, 2002

Key Executives

NameTitlePayYear Born
Li-Ching ChenPresident & Chairman0N/A
Teng-Yin ChangFinance Officer & Accounting Officer0N/A
AD

Description

LIWANLI Innovation Co., Ltd. operates within the biomedical science sector, concentrating on the development and distribution of nutrition and healthcare solutions. The company's diverse product portfolio, which notably features the Vigoway line and various powdered formulations, is designed to serve a wide range of consumers, including men, women, seniors, and children. Its extensive offerings encompass products such as probiotic enzymes, active nutrients, resveratrol red grape extract, and a variety of soft gels (including those with algae DHA, shea butter with type II collagen, and algae astaxanthin Q10). Other specialized items include cordyceps militaris powder, tooth guard tablets, bovine and goat's milk bites, bilberry tablets, and DHA and vitamin D3 drops, among others. The firm was formerly known as Carry Technology International Co., Ltd. before officially adopting its current name, LIWANLI Innovation Co., Ltd., in 2015. Established in 1980, the company's headquarters are located in New Taipei City, Taiwan.

AD